Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201212083 Principal Investigator: Baggstrom, Maria
Title: LUX-Lung EAP US: An open-label expanded access program of afatinib (BIBW 2992) for patients with locally advanced or metastatic non small cell lung cancer (NSCLC) harboring EGFR mutation(s)
Phase: N/A Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to provide patients with EGFR positive non-small cell lung cancer with access to afatinib. The study will also look at how well afatinib treats lung cancer and what side effects patients experience.
 
More Information:
ClinicalTrials.Gov
Internal Protocol Documents (requires Siteman administrative database password)